Newsbenzinga
HCA Healthcare Reports Prelim Q2 Sales Of ~$20.230B, Up From $18.605B YoY; Lowers FY2026 GAAP EPS From $29.10-$31.50 To $28.70-$30.50
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…